MARKET

BIOVF

BIOVF

Swedish Orphan Biovitrum Ab
OTCPK
41.32
NaN%
Closed 09:30 03/06 EST
OPEN
--
PREV CLOSE
41.32
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
41.55
52 WEEK LOW
27.00
MARKET CAP
14.28B
P/E (TTM)
278.06
1D
5D
1M
3M
1Y
5Y
1D
Swedish Orphan Biovitrum price target raised to SEK 470 from SEK 395 at Barclays
TipRanks · 02/24 17:10
Swedish Orphan Biovitrum price target raised to SEK 500 from SEK 470 at Berenberg
TipRanks · 02/23 18:00
Swedish Orphan Biovitrum downgraded to Hold from Buy at Danske Bank
TipRanks · 02/19 09:40
Sobi Sets Ambitious 2030 Target to Double Revenue on Wave of New Rare-Disease Launches
TipRanks · 02/18 09:18
Swedish Orphan upgraded to Outperform from Underperform at BNP Paribas
TipRanks · 02/10 10:00
Berenberg Bank Sticks to Its Buy Rating for Swedish Orphan Biovitrum AB (0MTD)
TipRanks · 02/09 08:36
Swedish Orphan Biovitrum AB reports Q4 results
Seeking Alpha · 02/05 11:39
Sobi Posts Strong 2025 Growth and Expands Rare Disease Portfolio With Strategic Deals and Launches
TipRanks · 02/05 08:05
More
About BIOVF
Swedish Orphan Biovitrum AB (publ) is a Sweden-based pharmaceutical company. The Company develops, manufactures and sells medications within hemophilia, autoimmune diseases, metabolic diseases and cancer supportive care. The Company’s product portfolio is divided into three business segments: the Core Products segment offers pharmaceuticals within Inflammation area, and Genetics and metabolic therapeutic area; the Partner Products segment offers about 40 pharmaceuticals within hematology, oncology and emergency medicines, and the ReFacto Manufacturing segment. The Company has subsidiaries in Sweden, Denmark, Finland, Norway, United Kingdom and France, among others.

Webull offers Swedish Orphan Biovitrum AB (publ) stock information, including OTCPK: BIOVF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BIOVF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BIOVF stock methods without spending real money on the virtual paper trading platform.